| Primary |
| Product Used For Unknown Indication |
22.3% |
| Dry Skin |
19.4% |
| Prophylaxis |
11.7% |
| Dermatitis Atopic |
9.7% |
| Pruritus |
7.8% |
| Eczema |
6.8% |
| Dermatitis |
3.9% |
| Dermatosis |
2.9% |
| Adverse Event |
1.9% |
| Dermatitis Allergic |
1.9% |
| Lichen Planus |
1.9% |
| Maternal Exposure During Pregnancy |
1.9% |
| Post Thrombotic Syndrome |
1.9% |
| Alopecia Areata |
1.0% |
| Dermatitis Contact |
1.0% |
| Drug Use For Unknown Indication |
1.0% |
| Inflammation |
1.0% |
| Myalgia |
1.0% |
| Tinea Pedis |
1.0% |
|
| Drug Ineffective |
13.9% |
| Loss Of Consciousness |
11.1% |
| Alveolitis Allergic |
5.6% |
| Blood Pressure Increased |
5.6% |
| Eczema |
5.6% |
| Incorrect Route Of Drug Administration |
5.6% |
| Medication Error |
5.6% |
| Product Quality Issue |
5.6% |
| Pruritus |
5.6% |
| Therapeutic Response Unexpected With Drug Substitution |
5.6% |
| Urticaria |
5.6% |
| Acarodermatitis |
2.8% |
| Application Site Haematoma |
2.8% |
| Chorioretinopathy |
2.8% |
| Depression |
2.8% |
| Drug Dependence |
2.8% |
| Dry Skin |
2.8% |
| Erythema |
2.8% |
| Growth Retardation |
2.8% |
| Hypersensitivity |
2.8% |
|
| Secondary |
| Drug Use For Unknown Indication |
14.9% |
| Eczema Infantile |
12.2% |
| Product Used For Unknown Indication |
12.2% |
| Dry Skin |
10.8% |
| Dermatitis Atopic |
8.1% |
| Eczema |
8.1% |
| Post Thrombotic Syndrome |
8.1% |
| Prophylaxis |
8.1% |
| Non-small Cell Lung Cancer |
4.1% |
| Acne |
2.7% |
| Depression |
2.7% |
| Pain |
2.7% |
| Dermatitis |
1.4% |
| Musculoskeletal Pain |
1.4% |
| Osteoarthritis |
1.4% |
| Rhinitis Allergic |
1.4% |
|
| Eczema |
17.6% |
| Loss Of Consciousness |
11.8% |
| Rash Pustular |
11.8% |
| Skin Wrinkling |
11.8% |
| Temperature Intolerance |
11.8% |
| Growth Retardation |
5.9% |
| Herpes Zoster |
5.9% |
| Liver Function Test Abnormal |
5.9% |
| Neutrophil Count Decreased |
5.9% |
| Product Quality Issue |
5.9% |
| Skin Atrophy |
5.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.5% |
| Drug Use For Unknown Indication |
13.9% |
| Eczema |
6.1% |
| Rash |
5.0% |
| Psoriasis |
4.8% |
| Breast Cancer |
4.4% |
| Osteoporosis |
4.3% |
| Non-small Cell Lung Cancer |
4.1% |
| Dermatitis Atopic |
3.9% |
| Depression |
3.5% |
| Chronic Obstructive Pulmonary Disease |
3.4% |
| Acne |
3.1% |
| Pain |
3.1% |
| Asthma |
2.8% |
| Hypertension |
2.2% |
| Multiple Allergies |
2.1% |
| Hepatitis C |
2.0% |
| Atrial Fibrillation |
1.7% |
| Premedication |
1.5% |
| Skin Disorder |
1.5% |
|
| Vomiting |
9.8% |
| Proctitis |
8.3% |
| Pulmonary Embolism |
7.6% |
| Renal Failure |
7.6% |
| Urinary Tract Infection |
6.8% |
| Tachycardia |
6.1% |
| Vaginal Infection |
6.1% |
| White Blood Cell Count Decreased |
6.1% |
| Thrombocytopenia |
4.5% |
| Erythrodermic Psoriasis |
3.8% |
| Lymphadenopathy |
3.8% |
| Toxic Skin Eruption |
3.8% |
| Weight Decreased |
3.8% |
| Weight Increased |
3.8% |
| Abortion Spontaneous |
3.0% |
| Electrocardiogram T Wave Amplitude Decreased |
3.0% |
| Myocardial Infarction |
3.0% |
| Psoriasis |
3.0% |
| Vasculitis |
3.0% |
| Vertigo |
3.0% |
|
